PRMT5 has been shown to regulate the expression of LRXα in BC cells and mouse models and promotes BC cell proliferation, invasion, and aerobic glycolysis in an NF-κBp65-dependent manner [149] (Figure 4). The gene discussed is PRMT5; the disease is breast cancer.